White House blocks NIH from awarding any research grants
Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT…
Vinay Prasad departs FDA | STAT
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
Trump order on ‘woke AI’ endangers science, weaponizes DEI
In late July, President Trump signed three executive orders relating to artificial intelligence as part of the administration’s…
UnitedHealth issues new, lower 2025 profit forecasts
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…
Medicare Savings Programs face cut, hospitals and insurers report Q2 results
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…
He took an ALS drug before getting sick — and it may have worked
For over an hour, Jeff Vierstra lay still in Columbia University’s ALS clinic, as a doctor poked him…
Rescission package vote casts shadow over health care initiatives
WASHINGTON — Congressional Republicans early on Friday morning passed legislation to take back money they had already appropriated…
We’re reading about GLP-1 drugs for addiction, FDA funding
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating,…
Sarepta Therapeutics lays off one-third of workforce in drastic cost-cutting move
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
Hospitals brace for Medicaid cuts, Humana’s latest Medicare doctor bet
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…